Herlev Pharma Service ApS: Financial statements 2025
CVR: 45308081
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Herlev Pharma Service ApS (CVR 45308081) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 420,981 and a net result of DKK -1,309,379. Equity in the 2025 report amounted to DKK -1,019,379. The company had 2 employees in the financial year.
- Gross Profit
- DKK 420,981
- Profit/Loss
- DKK -1,309,379
- Equity
- DKK -1,019,379
- Total Assets
- DKK 681,606
- Employees
- 2
Official annual report
How creditworthy is Herlev Pharma Service ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of June 24, 2025, Bo Tandrup has joined the board of directors of Herlev Pharma Service ApS.
As of June 24, 2025, Ørnulf Sandal has joined the board of directors of Herlev Pharma Service ApS.
As of June 24, 2025, Rasmus Kriegel is registered as director of Herlev Pharma Service ApS.
As of June 24, 2025, Pernille Bigaard has stepped down as liquidator of Herlev Pharma Service ApS.
On June 24, 2025, Herlev Pharma Service ApS exited liquidation.
As of May 7, 2025, Pernille Bigaard is registered as liquidator of Herlev Pharma Service ApS.
On May 7, 2025, Herlev Pharma Service ApS entered liquidation.
As of April 29, 2025, Bo Tandrup has left the board of directors of Herlev Pharma Service ApS.
As of April 29, 2025, Ørnulf Sandal has left the board of directors of Herlev Pharma Service ApS.
As of April 29, 2025, Rasmus Kriegel has stepped down as director of Herlev Pharma Service ApS.
About Herlev Pharma Service ApS
Herlev Pharma Service ApS is a Danish company of the type Anpartsselskab based in Herlev, founded in 2025. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Rasmus Kriegel. The board consists of Bo Tandrup (chair) and Daniel Petter Lunde. The company's owners include COMMERCE PHARMA HOLDING ApS, Morten Sølving Petersen and Balancial AS. According to the 2025 annual report, the company had an average of 2 employees. In 2025, the company reported a gross profit of DKK 420,981 and a net result of DKK -1,309,379. Equity in the 2025 report amounted to DKK -1,019,379.